Martin Wilson, General Counsel at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 4,100 shares at $29.33 ($120K) on 2024-02-29, disclosed to the SEC on 2024-03-04.
Open-market sale of $120k RCKT by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2026-08-17 | $12K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $2K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $12K | — | Filing → |